Fenofibrate for Patients With COVID-19 Requiring Hospitalization
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This is an open-label run-in followed by a randomized, double-blind drug treatment study of
COVID-19 infected patients requiring inpatient hospital admission.